A Business Insider reporter said the cost of Daraprim would still be around $900 a pill at her local pharmacy Wednesday. And so Turing Pharmaceuticals CEO Martin Shkreli still seemingly hasn't lowered the price of anti-infection drug Daraprim, despite promising to do so after widespread outrage two weeks ago. Shkreli's startup bought the drug, used to treat infections in AIDS patients and others with comproised immune systems, and hiked its price 5000% percent to $750 per dose. “We’ve agreed to lower the price of Daraprim to a point that is more affordable and is able to allow the company to make a profit, but a very small profit," he told ABC News in September.
TOP 10 RIGHT NOW